Cell line and drug

Publication Title Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukem
DOI https://doi.org/10.1186/1756-8722-6-21
Year 2013
 
 
Please select
 
 
miRNA ID
Trait, Trait subtype
Cell Line
Drug 1
Drug 2
Drug 3
  
MIMAT0004495 Acute Myeloid Leukemia (AML), FLT3-ITD positive MV4-11 Silvestrol Not Applicable Not Applicable
MIMAT0001618 Acute Myeloid Leukemia (AML), FLT3-wild type overexpression THP-1 Silvestrol Not Applicable Not Applicable
MIMAT0001618 Acute Myeloid Leukemia (AML), FLT3-ITD positive MV4-11 Silvestrol Not Applicable Not Applicable
Count 3